Term
principle heme found in Hb and Mb |
|
Definition
|
|
Term
|
Definition
produced in all cells, synthesis most pronounced in bone marrow and liver |
|
|
Term
What proteins contain heme? |
|
Definition
Mb, Hb, microsomal and mitochondrial cytochromes (electron-transport proteins, iron must be in Fe3+ form), enzymes (catalase, peroxidase, tryptophan pyrrolase, prostaglandin synthase, guanylate cyclase, NO synthase) |
|
|
Term
Heme biosynthesis
location, major enzymes |
|
Definition
ALA synthase (E1) and ferrochelatase (E8) act in mitochondria, the intermed. steps take place in cytosol
|
|
|
Term
|
Definition
converts succinyl CoA to dALA in first step of heme biosynthesis.
**rate-limiting step |
|
|
Term
ingredients needed for heme biosynthesis |
|
Definition
succinyl CoA (Kreb's cycle intermediate), glycine residues (from cytosol), iron ion (from cytosol--delivered from liver, where dietary iron is stored) |
|
|
Term
|
Definition
Heme A--cytochrome A
Heme B--Hb, Mb
Heme C--cytochrome C |
|
|
Term
E7 of heme biosynthetic pathway converts _______ to ____________ |
|
Definition
protoporphyrinogen to protoporphyrin
occurs in mitochondria |
|
|
Term
ALAS (name, basic function, location, coenzyme) |
|
Definition
ALAS (delta-Aminolevulinic Acid Synthase)
rate-limiting and regulated enzyme
acts in cytosol
vitamin B6 coenzyme |
|
|
Term
|
Definition
ALAS-E (aka ALAS2) erythroid
ALAS-N (aka ALAS1) nonspecific |
|
|
Term
|
Definition
Heme: feedback inhibition (represses transcription and activity)
Iron ion availability: regulates only ALAS-E in developing erythrocytes |
|
|
Term
|
Definition
inherited ALAS-E deficiency
X-linked
other causes include copper/lead/zinc poisoning, B6/copper deficiency |
|
|
Term
|
Definition
diseases (hereditary or acquired) characterized by breakdown of heme biosynthetic control mechanisms |
|
|
Term
Porphyrias (manifestation) |
|
Definition
excretion and accumulation of heme biosynthetic intermediates |
|
|
Term
|
Definition
lack of one biosynthetic enzyme, which results in decline in heme levels, causing activation of ALAS expression and activity, which drives accumulation of intermediates |
|
|
Term
|
Definition
hereditary: after puberty, due to appearance of 5β-reductase, used in sex hormone biosynthesis. Sex hormones stimulate ALAS synthesis |
|
|
Term
Porphyria classification (by cause and by symptoms) |
|
Definition
Cause--acquired and hereditary
Symptoms--neurologic, cutaneous, neurologic-cutaneous (mixed) |
|
|
Term
|
Definition
lead poisoning (inhibits ALAS-E)
iron deficiency (protoporphyrin IX is excreted in feces bc it's insoluble) |
|
|
Term
|
Definition
Acute intermittent porphyria: due to E3 deficiency, can result in permanant nerve damage or death. Symptoms caused by elevated ALA. Tx of acute attacks=hemin injection (represses ALAS transcription in non-erythroid tissues) |
|
|
Term
|
Definition
Cutaneous porphyria
Ferrochelatase (E8) levels are down, causing excretion of protoporphyrin IX in feces. Liver and erythropoietic tissues affected. |
|
|
Term
Catabolism of heme-containing proteins |
|
Definition
1. degrade globin
2. process hydrophobic products of porphyrin ring cleavage
3. retain/reutilize contained iron |
|
|
Term
Danger in elimination of heme products |
|
Definition
free heme, protoporphyrin degradation products, and free iron are pro-oxidants
free heme is very apolar and very inflammatory
-->CELL INJURY |
|
|
Term
Heme catabolism: enz and products |
|
Definition
enzyme: heme oxygenase, req oxygen and NADPH
heme-->CO (only endogenous source), bilirubin and Fe3+
bilirubin sent to liver for further processing,
iron released in ferrous form, bound by ferritin |
|
|
Term
|
Definition
biliverdin-->bilirubin IX
req NADPH |
|
|
Term
|
Definition
binds ferrous ion (heme degradation product) |
|
|
Term
|
Definition
heme degradation product
poorly soluble, therefore needs transporter in blood (albumin)
conjugated with glucuronic acid in liver
bilirubin diglucuronide-->secreted in bile-->intestine-->feces |
|
|
Term
uridine diphosphoglucuronate |
|
Definition
serves as glucuronate donor to bilirubin, making it soluble as bilirubin diglucuronide |
|
|
Term
|
Definition
very little in blood, water soluble
elevation-->yellow urine
deposition-->sclera/skin jaundice |
|
|
Term
|
Definition
bound non-covalently to albunin
majority of serum bilirubin
hi affinity for membrane lipids-->impairment of memb fn |
|
|
Term
covalently-bound bilirubin |
|
Definition
covalently-bound to albumin
only present in hepatocellular disease
in some cases, up to 90% of total bilirubin can be in this form |
|
|
Term
|
Definition
elevation in unconjugated bilirubin or elevation in both un- and conjugated bilirubin |
|
|
Term
accumulation of both unconjugated and conjugated bilirubin |
|
Definition
hepatitis, cirrhosis
proportion of conjugated bilirubin increases |
|
|
Term
accumulation of unconjugated bilirubin |
|
Definition
increased production:
hemolysis, ineffective erythropoiesis, massive tissue necrosis or hematomas
decreased clearance:
drug-induced, physiological neonatal jaundice/prematurity, liver diseases(advanced hepatitis/ cirrhosis), Crigler-Najjar syndrome, Gilbert syndrome |
|
|
Term
|
Definition
unconjugated hyperbilirubinemia
neonatal jaundice |
|
|
Term
Crigler-Najjar syndrome (types, cause) |
|
Definition
unconjugated hyperbilirubinemia
autosomal recessive
glucuronyl transferase gene mutation-->bilirubin can't be conjugated
unconj. bilirubin levels rise
type 1 bilirubin encephalopathy (kernicterus) and severe jaundice and brain damage
type 2 lower serum bilirubin conc., no neuro impairmt
|
|
|
Term
neonatal or physiological jaundice |
|
Definition
HbF dies off, causing increase in serum bilirubin conc, which developing liver can't handle
usually, self-resolves in a few days as liver matures
can be treated with UV light (makes bilirubin water soluble, excreted in urine) |
|
|
Term
|
Definition
body doesn't have enough healthy blood cells due to:
*underproduction of mature RBCs
*loss of RBCs |
|
|
Term
|
Definition
inflammation, neoplasia, chronic disease, iron deficiency, maturation disorders, hemolytic anemias, acute bleeding, marrow damage |
|
|
Term
|
Definition
jaundice, dizziness/fainting, fatigue, low bp, heart attack, angina, splenomegaly, shortness of breath, weakness/fatigue |
|
|
Term
Idopathic aplastic anemia |
|
Definition
bone marrow fails to properly make blood cells
cause: damage to blood stem cells, autoimmune, pregnancy, lupus, toxin/drug exposure (chemo)
RBCs abnormal in shape and form, many damaged |
|
|
Term
|
Definition
bone marrow disorder, marrow poorly developed -->anemia |
|
|
Term
|
Definition
defect in proteins that repair DNA, often bone marrow failure-->anemia |
|
|
Term
|
Definition
larger-than-normal RBCs due to folic acid or B12 deficiency (nucleotide/DNA synth) |
|
|
Term
|
Definition
dec in RBCs when body can't properly absorb B12 from GI tract |
|
|
Term
|
Definition
less Hb than normal is deposited in the cells |
|
|
Term
|
Definition
small RBCs (low mean corpuscular volume--MCV) |
|
|
Term
|
Definition
20% of women, 50% of pregnant women, 3% of men
caused by: blood loss, poor iron absorption, too little dietary iron, lead poisoning in children |
|
|
Term
|
Definition
loss of RBCs
intrinsic reasons: abnormalities in RBC proteins, hemoglobinopathies
extrinsic reasons: abnormal immune system response, blood clots in sm vessels, certain infections, medication side effects |
|
|
Term
Congenital spherocytic anemia |
|
Definition
RBC membrane disorder--> spherical RBCs/lysis
can also have elliptocytosis or ovalocytosis |
|
|
Term
|
Definition
HbS and HbC point mutations |
|
|
Term
idiopathic autoimmune hemolytic anemia |
|
Definition
immune system destroys body's own RBCs for unknown reason |
|
|
Term
|
Definition
reduced RBC count due to premature hemolysis, Rh factor difference between mother and fetus or transfusion of blood from donor w diff blood type |
|
|
Term
|
Definition
lyses RBCs (parasite lives in RBC) |
|
|
Term
Microangiopathic hemolytic anemia (MAHA) |
|
Definition
RBCs destroyed as they travel through damaged small blood vessels (intravascular thrombi) |
|
|